Background. This study focus on the effect of 6 months transdermal estradio
l therapy (TTS) on the sexual behaviour and the quality of life in early me
nopausal women, complaining of uncomfortable menopausal symptoms.
Methods. Three hundred and sixty-two postmenopausal women, aged 48-56, part
icipated in this study. One hundred and seventy-one of them were given cont
inuous solid matrix patch TTS 50 mug/day for 6 months. Sexual behaviour, me
nopausal symptoms and well-being were evaluated through a self-rating metho
d. We used a structured questionnaire with three obligatory answers (less/s
ame/more) for each question-sexual life, hot flushes, touchiness, insomnia,
blood pressure, work willing, memory loss, well-being-, filled in by the w
omen themselves or by the medical equipe after a telephone interview.
Results. Seventy five per cent of women aged 51-53 and 84% aged 54-56, who
had been treated for 6 months with TTS showed a fall of sexual drive, if co
mpared with, respectively, 62% and 48% of untreated subjects. Relief of hot
flushes, touchiness and insomnia occurred in 80% of treated women, with sl
ight differences among the various groups while 61% showed increase of well
-being.
Conclusions. The results of our study demonstrate that continuous TTS for 6
months decreased sexual drive in 69% of women, improved menopausal symptom
s in 80% women but increased well-being only in 61% of women. These differe
nces suggest that women's well-being does not seem linked only to the relie
f of menopausal symptoms and the impairment of their sexual life can play a
negative role.